Henriksen Maiken Lumby, Nielsen Christian, Pedersen Dennis, Andersen Gregers Rom, Thiel Steffen, Palarasah Yaseelan, Hansen Soren Werner Karlskov
Dept. of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Dept. of Clinical Immunology, Odense University Hospital, Odense, Denmark.
J Immunol Methods. 2022 Aug;507:113295. doi: 10.1016/j.jim.2022.113295. Epub 2022 Jun 6.
Factor D (also known as adipsin) is a serine protease and part of the complement system, involved in innate immune responses and effector functions of antibodies. Factor D cleaves factor B complexed with C3b, leading to the C3 convertase C3bBb. This C3 convertase is central in the alternative activation pathway and the amplification loop, which amplifies the two other complement activation pathways: the classical pathway and the lectin pathway. Adipocytes synthesize factor D as a pro-form comprising 6 additional residues that must be cleaved off to generate a mature form. The MBL-associated serine protease 3 (MASP-3), found in complex with the pattern recognition molecules of lectin activation pathway, converts the pro-form to mature factor D, which reportedly is the most abundant form found in the circulation at concentrations of 1-2 μg/ml among healthy individuals. The mature factor D is rate-limiting for complement activation, but little is known about the distribution of pro vs. mature factor D in the circulation, the regulation hereof and the potential activation stimuli of the lectin pathway, responsible for activation of MASP-3 and subsequent conversion of pro-form of factor D. In this light we established and validated an ELISA specific for measuring the pro-form of complement factor D. With a working range of 0.82-25 ng/ml, acceptable intra and inter assay CVs, and a relative recovery rate above 90%, we found that the median plasma concentration in Danish blood donors was 134 ng/ml; corresponding to that 8-15% factor D circulates as pro-form. We also found that blood sampling procedures affect conversion and hence the levels measured in serum and plasma.
D因子(也称为脂肪酶)是一种丝氨酸蛋白酶,是补体系统的一部分,参与先天免疫反应和抗体的效应功能。D因子可切割与C3b结合的B因子,产生C3转化酶C3bBb。这种C3转化酶在替代激活途径和放大环中起核心作用,该放大环可放大另外两条补体激活途径:经典途径和凝集素途径。脂肪细胞合成的D因子为前体形式,包含6个额外的残基,必须切除这些残基才能产生成熟形式。与凝集素激活途径的模式识别分子形成复合物的MBL相关丝氨酸蛋白酶3(MASP-3)可将前体形式转化为成熟的D因子,据报道,成熟的D因子是健康个体循环中最丰富的形式,浓度为1-2μg/ml。成熟的D因子是补体激活的限速因子,但关于循环中前体与成熟D因子的分布、其调节以及凝集素途径的潜在激活刺激(负责激活MASP-3并随后将D因子的前体形式转化)知之甚少。鉴于此,我们建立并验证了一种特异性检测补体D因子前体形式的ELISA方法。该方法的工作范围为0.82-25 ng/ml,批内和批间CV可接受,相对回收率高于90%,我们发现丹麦献血者的血浆中位数浓度为134 ng/ml;这表明8-15%的D因子以前体形式循环。我们还发现采血程序会影响转化,从而影响血清和血浆中测得的水平。